Covid 19 Diagnostics Market Insights, Competitive Landscape, and Market Forecast

Description

The Covid-19 Diagnostics Market continues to evolve as healthcare systems worldwide shift from emergency response to long-term disease monitoring and preparedness. The market is estimated to reach USD 4.6 billion in 2026 and is projected to expand to USD 6.9 billion by 2033, registering a compound annual growth rate (CAGR) of 6.00%. Although the acute phase of the pandemic has subsided, the importance of reliable diagnostic solutions remains critical for managing outbreaks, detecting new variants, and strengthening global health security frameworks.

Market Insights

The market landscape has transitioned toward routine surveillance, preventive healthcare, and decentralized diagnostic approaches. Molecular testing methods, particularly PCR, continue to dominate due to their high precision and sensitivity. However, rapid diagnostic technologies such as lateral flow assays and point-of-care testing are increasingly gaining adoption because of their speed and convenience.

The growing availability of home testing kits has significantly reshaped the market, allowing individuals to perform tests without visiting healthcare facilities. In addition, the integration of digital tools such as cloud-based reporting systems and AI-driven analytics is improving diagnostic accuracy and operational efficiency. These innovations are expected to support sustained market growth in the coming years.

Drivers

One of the primary drivers of the Covid-19 diagnostics market is the continued need for monitoring and controlling virus transmission. The emergence of new variants necessitates ongoing testing and surveillance efforts across regions. Governments and health organizations are actively promoting testing as a key strategy in public health management.

The increasing preference for rapid and point-of-care diagnostics is another major growth factor. These solutions provide quick results, enabling faster decision-making and reducing the burden on centralized laboratories. Additionally, rising public awareness regarding infectious diseases and preventive healthcare is encouraging higher adoption of diagnostic tests.

Significant investments in healthcare infrastructure and diagnostic capabilities since the pandemic have also strengthened the market. Enhanced laboratory networks, improved supply chains, and increased funding for research and development are contributing to the steady expansion of the industry.

Business Opportunity

The Covid-19 diagnostics market offers promising opportunities for innovation and expansion. Companies are focusing on the development of multiplex testing platforms that can detect multiple respiratory infections, including Covid-19, influenza, and other viruses, in a single test. This approach enhances efficiency and provides broader clinical insights.

Emerging economies present considerable growth potential due to increasing healthcare investments and demand for affordable diagnostic solutions. Manufacturers are working on cost-effective testing kits and scalable technologies to cater to these markets.

The integration of digital health technologies also represents a key opportunity. Mobile applications, telehealth platforms, and data analytics tools are enabling better tracking of infection trends and improving patient management. Companies investing in digital integration are likely to gain a competitive edge.

Region Analysis

North America continues to lead the Covid-19 diagnostics market, supported by advanced healthcare infrastructure, high testing volumes, and the presence of major industry players. The region's focus on innovation and regulatory support further strengthens its market position.

Europe remains a significant contributor, driven by comprehensive public health programs and ongoing surveillance initiatives. Governments across the region continue to invest in diagnostic capabilities to ensure preparedness for future outbreaks.

Asia Pacific is expected to experience the fastest growth during the forecast period. Factors such as expanding healthcare infrastructure, large population base, and increasing awareness about diagnostic testing are fueling market expansion. Countries such as China, India, and Japan are actively enhancing their diagnostic systems.

Latin America and the Middle East & Africa are gradually emerging as important markets. While these regions face certain challenges, including limited resources and infrastructure constraints, ongoing efforts to improve healthcare access and diagnostic availability are expected to support growth.

Key Players

The Covid-19 diagnostics market is characterized by intense competition and continuous innovation. Leading companies operating in the market include:

Abbott Laboratories
Thermo Fisher Scientific Inc.
Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
Siemens Healthineers AG
Danaher Corporation (including Beckman Coulter)
Bio-Rad Laboratories, Inc.
QuidelOrtho Corporation
Becton, Dickinson and Company (BD)
PerkinElmer, Inc.
Hologic, Inc.
Cepheid (Danaher Group)
Mesa Biotech (now part of Thermo Fisher)
Abbott Rapid Diagnostics (Alere)
Seegene, Inc.
Meridian Bioscience, Inc.

These players are focusing on product innovation, strategic collaborations, and expansion of distribution networks to strengthen their market presence. Continuous advancements in diagnostic technologies remain a key competitive factor.

Segmentation

By Product

Instruments
Reagents & Kits

By Technology

Polymerase Chain Reaction (PCR)
Enzyme-Linked Immunosorbent Assay (ELISA)
Lateral Flow Immunoassay (LFIA)
Others

By Sample Type

Oropharyngeal & Nasopharyngeal Swabs
Nasal Swabs
Blood

By Setting

Lab-based
Point of Care

By End-user

Hospitals & Clinics
Laboratories & Diagnostic Centers
Home Testing
Others

By Geography

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Covid 19 Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors

3. Global Covid 19 Diagnostics Market Outlook, 2020 - 2033

3.1. Global Covid 19 Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 3.1.1. Instruments
- 3.1.2. Reagents & Kits
3.2. Global Covid 19 Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
- 3.2.1. Polymerase Chain Reaction (PCR)
- 3.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 3.2.3. Lateral Flow Immunoassay (LFIA)
- 3.2.4. Others
3.3. Global Covid 19 Diagnostics Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
- 3.3.1. Oropharyngeal & Nasopharyngeal Swabs
- 3.3.2. Nasal Swabs
- 3.3.3. Blood
3.4. Global Covid 19 Diagnostics Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 3.4.1. Lab-based
- 3.4.2. Point of Care
- 3.4.3. By End-user
- 3.4.4. Hospitals & Clinics
- 3.4.5. Laboratories & Diagnostic Centers
- 3.4.6. Home Testing
- 3.4.7. Others
3.5. Global Covid 19 Diagnostics Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa

4. North America Covid 19 Diagnostics Market Outlook, 2020 - 2033

4.1. North America Covid 19 Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 4.1.1. Instruments
- 4.1.2. Reagents & Kits
4.2. North America Covid 19 Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
- 4.2.1. Polymerase Chain Reaction (PCR)
- 4.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 4.2.3. Lateral Flow Immunoassay (LFIA)
- 4.2.4. Others
4.3. North America Covid 19 Diagnostics Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
- 4.3.1. Oropharyngeal & Nasopharyngeal Swabs
- 4.3.2. Nasal Swabs
- 4.3.3. Blood
4.4. North America Covid 19 Diagnostics Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 4.4.1. Lab-based
- 4.4.2. Point of Care
- 4.4.3. By End-user
- 4.4.4. Hospitals & Clinics
- 4.4.5. Laboratories & Diagnostic Centers
- 4.4.6. Home Testing
- 4.4.7. Others
4.5. North America Covid 19 Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 4.5.2. U.S. Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 4.5.3. U.S. Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 4.5.4. U.S. Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 4.5.5. Canada Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 4.5.6. Canada Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 4.5.7. Canada Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 4.5.8. Canada Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Covid 19 Diagnostics Market Outlook, 2020 - 2033

5.1. Europe Covid 19 Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 5.1.1. Instruments
- 5.1.2. Reagents & Kits
5.2. Europe Covid 19 Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
- 5.2.1. Polymerase Chain Reaction (PCR)
- 5.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 5.2.3. Lateral Flow Immunoassay (LFIA)
- 5.2.4. Others
5.3. Europe Covid 19 Diagnostics Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
- 5.3.1. Oropharyngeal & Nasopharyngeal Swabs
- 5.3.2. Nasal Swabs
- 5.3.3. Blood
5.4. Europe Covid 19 Diagnostics Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 5.4.1. Lab-based
- 5.4.2. Point of Care
- 5.4.3. By End-user
- 5.4.4. Hospitals & Clinics
- 5.4.5. Laboratories & Diagnostic Centers
- 5.4.6. Home Testing
- 5.4.7. Others
5.5. Europe Covid 19 Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 5.5.2. Germany Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 5.5.3. Germany Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 5.5.4. Germany Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 5.5.5. Italy Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 5.5.6. Italy Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 5.5.7. Italy Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 5.5.8. Italy Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 5.5.9. France Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 5.5.10. France Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 5.5.11. France Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 5.5.12. France Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 5.5.13. U.K. Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 5.5.14. U.K. Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 5.5.15. U.K. Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 5.5.16. U.K. Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 5.5.17. Spain Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 5.5.18. Spain Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 5.5.19. Spain Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 5.5.20. Spain Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 5.5.21. Russia Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 5.5.22. Russia Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 5.5.23. Russia Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 5.5.24. Russia Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 5.5.25. Rest of Europe Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 5.5.26. Rest of Europe Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 5.5.27. Rest of Europe Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 5.5.28. Rest of Europe Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Covid 19 Diagnostics Market Outlook, 2020 - 2033

6.1. Asia Pacific Covid 19 Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 6.1.1. Instruments
- 6.1.2. Reagents & Kits
6.2. Asia Pacific Covid 19 Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
- 6.2.1. Polymerase Chain Reaction (PCR)
- 6.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 6.2.3. Lateral Flow Immunoassay (LFIA)
- 6.2.4. Others
6.3. Asia Pacific Covid 19 Diagnostics Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
- 6.3.1. Oropharyngeal & Nasopharyngeal Swabs
- 6.3.2. Nasal Swabs
- 6.3.3. Blood
6.4. Asia Pacific Covid 19 Diagnostics Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 6.4.1. Lab-based
- 6.4.2. Point of Care
- 6.4.3. By End-user
- 6.4.4. Hospitals & Clinics
- 6.4.5. Laboratories & Diagnostic Centers
- 6.4.6. Home Testing
- 6.4.7. Others
6.5. Asia Pacific Covid 19 Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 6.5.2. China Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 6.5.3. China Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 6.5.4. China Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 6.5.5. Japan Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 6.5.6. Japan Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 6.5.7. Japan Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 6.5.8. Japan Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 6.5.9. South Korea Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 6.5.10. South Korea Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 6.5.11. South Korea Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 6.5.12. South Korea Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 6.5.13. India Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 6.5.14. India Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 6.5.15. India Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 6.5.16. India Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 6.5.17. Southeast Asia Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 6.5.18. Southeast Asia Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 6.5.19. Southeast Asia Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 6.5.20. Southeast Asia Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 6.5.21. Rest of SAO Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 6.5.22. Rest of SAO Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 6.5.23. Rest of SAO Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 6.5.24. Rest of SAO Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Covid 19 Diagnostics Market Outlook, 2020 - 2033

7.1. Latin America Covid 19 Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 7.1.1. Instruments
- 7.1.2. Reagents & Kits
7.2. Latin America Covid 19 Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
- 7.2.1. Polymerase Chain Reaction (PCR)
- 7.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 7.2.3. Lateral Flow Immunoassay (LFIA)
- 7.2.4. Others
7.3. Latin America Covid 19 Diagnostics Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
- 7.3.1. Oropharyngeal & Nasopharyngeal Swabs
- 7.3.2. Nasal Swabs
- 7.3.3. Blood
7.4. Latin America Covid 19 Diagnostics Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 7.4.1. Lab-based
- 7.4.2. Point of Care
- 7.4.3. By End-user
- 7.4.4. Hospitals & Clinics
- 7.4.5. Laboratories & Diagnostic Centers
- 7.4.6. Home Testing
- 7.4.7. Others
7.5. Latin America Covid 19 Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 7.5.2. Brazil Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 7.5.3. Brazil Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 7.5.4. Brazil Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 7.5.5. Mexico Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 7.5.6. Mexico Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 7.5.7. Mexico Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 7.5.8. Mexico Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 7.5.9. Argentina Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 7.5.10. Argentina Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 7.5.11. Argentina Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 7.5.12. Argentina Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 7.5.13. Rest of LATAM Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 7.5.14. Rest of LATAM Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 7.5.15. Rest of LATAM Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 7.5.16. Rest of LATAM Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Covid 19 Diagnostics Market Outlook, 2020 - 2033

8.1. Middle East & Africa Covid 19 Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 8.1.1. Instruments
- 8.1.2. Reagents & Kits
8.2. Middle East & Africa Covid 19 Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
- 8.2.1. Polymerase Chain Reaction (PCR)
- 8.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 8.2.3. Lateral Flow Immunoassay (LFIA)
- 8.2.4. Others
8.3. Middle East & Africa Covid 19 Diagnostics Market Outlook, by Sample Type, Value (US$ Bn), 2020-2033
- 8.3.1. Oropharyngeal & Nasopharyngeal Swabs
- 8.3.2. Nasal Swabs
- 8.3.3. Blood
8.4. Middle East & Africa Covid 19 Diagnostics Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 8.4.1. Lab-based
- 8.4.2. Point of Care
- 8.4.3. By End-user
- 8.4.4. Hospitals & Clinics
- 8.4.5. Laboratories & Diagnostic Centers
- 8.4.6. Home Testing
- 8.4.7. Others
8.5. Middle East & Africa Covid 19 Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 8.5.2. GCC Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 8.5.3. GCC Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 8.5.4. GCC Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 8.5.5. South Africa Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 8.5.6. South Africa Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 8.5.7. South Africa Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 8.5.8. South Africa Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 8.5.9. Egypt Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 8.5.10. Egypt Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 8.5.11. Egypt Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 8.5.12. Egypt Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 8.5.13. Nigeria Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 8.5.14. Nigeria Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 8.5.15. Nigeria Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 8.5.16. Nigeria Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
- 8.5.17. Rest of Middle East Covid 19 Diagnostics Market Outlook, by Product, 2020-2033
- 8.5.18. Rest of Middle East Covid 19 Diagnostics Market Outlook, by Technology, 2020-2033
- 8.5.19. Rest of Middle East Covid 19 Diagnostics Market Outlook, by Sample Type, 2020-2033
- 8.5.20. Rest of Middle East Covid 19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Abbott Laboratories
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. Thermo Fisher Scientific Inc.
- 9.4.3. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
- 9.4.4. Siemens Healthineers AG
- 9.4.5. Danaher Corporation (including Beckman Coulter)
- 9.4.6. Bio-Rad Laboratories, Inc.
- 9.4.7. QuidelOrtho Corporation
- 9.4.8. Becton, Dickinson and Company (BD)
- 9.4.9. PerkinElmer, Inc.
- 9.4.10. Hologic, Inc.
- 9.4.11. Cepheid (Danaher Group)
- 9.4.12. Mesa Biotech (now part of Thermo Fisher)
- 9.4.13. Abbott Rapid Diagnostics (Alere)
- 9.4.14. Seegene, Inc.
- 9.4.15. Meridian Bioscience, Inc.

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Covid 19 Diagnostics Market Insights, Competitive Landscape, and Market Forecast - 2033